Article
High PRMT5 expression is associated with poor overall survival and tumor progression in bladder cancer
11 May 2020
Abstract excerpt
Arginine methyltransferase 5 (PRMT5) is involved in a variety of cancers. We used bioinformatics analysis to investigate PRMT5 overexpression in bladder urothelial cancer (BUC) and its clinical significance. We also conducted molecular biology experiments to investigate the effect of PRMT5 on the phenotype of BUC cells in vitro and in vivo. PRMT5 was found to be upregulated in BUC tissue in the Oncomine and The...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
